Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹196.82
7.46 (3.94%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹950 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
36.9
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹107+83.9%
52W High₹219-10.1%
Current Price
₹196.82
Circuit Limits (5%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹186.98
Upper Circuit₹206.66
Reference Price
₹196.82
Investment Checklist
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹206.29
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹201.44
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 49.74 (BUY) with 53.7% confidence
Volume divergence: Bearish (price up, volume down)
Technical Analysis
Technical Analysis
Analysis from 2026-07-11
Confidence
54%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
188.95
EMA50
179.31
EMA200
162.96
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows5
Lower Highs4
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹213.50
₹219.00
Support (Below)
₹186.42
₹180.77
₹175.55
₹173.00
₹170.08
Volume Analysis
TrendDECREASING
Change-32.30%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹194.85
3% Risk₹190.92
5% Risk₹186.98
7% Risk (Custom)
₹183.04Technical Levels
1x ATR (Volatility)₹187.16
2x ATR (Swing)₹177.50
3x ATR (Trend)₹167.84
Immediate Support₹186.42
Moving Averages
EMA 9 (Short-term)₹190.71
EMA 20 (Medium-term)₹188.95
EMA 50 (Trend)₹179.31
EMA 200 (Long-term)₹162.96
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹172.4 Cr | ₹135.2 Cr | ₹117.9 Cr | ₹194.3 Cr |
| Net Profit | ₹9.7 Cr | ₹7.4 Cr | ₹-9.9 Cr | ₹9.3 Cr |
| EPS | — | ₹1.54 | ₹-2.06 | ₹1.93 |
| Operating Profit | ₹20.3 Cr | ₹16.7 Cr | ₹-5.3 Cr | ₹17.8 Cr |
ROE
7.44%
ROCE
8.96%
Debt/Equity
0.29
Current Ratio
1.76
OPM
9.18%
NPM
4.81%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.7 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.6 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 22.8 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.3 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.1 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.1 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 25.7 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 93.4 | ₹83.02K Cr mid Cap | |
| Kopran Limited | ₹196.82 | +3.94% | 36.9 | ₹950 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 04 Sept 2025 | Dividend - Rs 3 Per Share | DIVIDEND |
| 02 Sept 2024 | Annual General Meeting/Dividend - Rs 3 Per Share | AGM |
| 07 Sept 2023 | Annual General Meeting/Dividend - Rs 3 Per Share | AGM |
| 04 Aug 2022 | Dividend - Rs 3 Per Share | DIVIDEND |
| 05 Aug 2021 | Dividend - Rs 1.50 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for KOPRAN
View AllNEWS
positive
Business Standard - Markets 53d ago
Kopran consolidated net profit rises 94.94% in the March 2026 quarter
Sales rise 35.77% to Rs 234.02 crore
KOPRANHealthcare
positive
ET Markets - Stocks 91d ago
Madhusudan Kela picks beaten-down smallcap bets; buys Indiabulls, Simplex Infra in Q4
Ace investor Madhusudan Kela has bought stakes in Indiabulls Limited and Simplex Infrastructures Limited. These companies have seen recent underperformance. Kela's move signals a contrarian investment strategy. His portfolio includes other companies like Kopran and Bombay Dyeing. This selective accumulation in beaten-down stocks is a key highlight.
ACEBFINVESTBOMDYEINGIBULLSLTDINFRAKOPRANMADHUSUDANSIMPLEXINFSMALLCAPCapital GoodsConstruction